Biggest News Aggregation in the World
๐Ÿ“ฐ Beta Trap News

Beta Trap News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beta Trap. Real-time updates on events, politics, business and more.

Precigen Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated Approval

โ€“ ย  FDA confirmed that the ongoing Phase 1/2 single arm study will serve as pivotal and no additional randomized, placebo-controlled trial will be required to support submission of a...
Stevenm Harasym Clintt Allen Scott Norberg Precigen Adenoverse Kim Mcclellan National Institutes Of Health

Precigen to Present Latest Clinical Advancements for PRGN-3005 UltraCAR-T® and PRGN-2009 Off-the-Shelf AdenoVerse™ Immunotherapy at the 2023 ASCO Annual Meeting

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...
United States Mccormick Place Precigen Ultra Stevenm Harasym Precigen Adenoverse Immunotherapy Clinical Program

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science